GLP-1 only) and is FDA-approved for weight losswhile Ozempic is only approved for type 2 diabetes
These products fall under dietary supplement rules set by the Dietary Supplement Health and Education Act (DSHEA) [6]
The location, timing, severity, and pattern of the pain can help your provider determine whether the treatment plan needs to change or whether another condition should be investigated
Ideal candidates for GLP-1 weight loss treatments are adults who struggle with obesity or have a BMI over 30, and those with weight-related medical conditions such as type 2 diabetes
A serious systemic disturbance called metabolic acidosis can occur in CKD when acidic compounds, especially nitrogen-containing waste from dietary protein metabolism, accumulate in the blood
Retatrutide should be considered a second-line or specialized first-line agent for complex cases once it gains regulatory approval